1.Over-expression of MMP-3 in the fissured tissue of cleft lip and palate.
Young Wook PARK ; Bong Gi MIN ; Ji Hyuck KIM ; Soung Min KIM ; Young Joon LEE ; Sang Shin LEE ; Suk Keun LEE ; Huck Soo MOON ; Je Geun CHI
Journal of the Korean Association of Oral and Maxillofacial Surgeons 2006;32(1):19-26
OBJECTIVE: In order to elucidate the retrogressive degeneration of orofacial cleft, the fissured tissues of prenatal and postnatal cleft lip and palate were examined by histological and immunohistochemical methods. DESIGN: Totally 42 cases of prenatal (n=17) and postnatal (n=25) cleft lip and/or palate were examined in comparison with 10 cases of normal lip and oral mucosa using immunohistochemical stainings of MMP-3, MMP-9, MMP-10, cathepsin G, PCNA, E-cadherin, TGase 2, HSP-70, vWF, and VEGF. MAIN OUTCOME MEASURES: In the fissured tissue the sebaceous glands were strongly positive for PCNA and grew into the underlying fibromuscular tissue (24/42). Some hyperplastic sebaceous glands of prenatal cleft lip produced infundibular follicular cyst (9/17). The skin and mucosal epithelia from the postnatal cleft lip and palate (10/25) showed severe basal hyperplasia (11/25) and melanocyte infiltration (7/25). RESULTS: The immunostaining of MMP-3 and HSP-70 were strongly positive in the hyperplastic sebaceous glands and nearby atrophying muscle bundles of the fissured tissue, while MMP-9, MMP-10, and cathepsin G were almost negative. The immunoreactions of the other antibodies used in this study were similar between in the fissured tissues and in the normal controls. CONCLUSIONS: These data suggest that the over-expression of MMP-3 is closely related to the sebaceous gland hyperplasia, epithelial dysplasia, and the muscle degeneration, and that the over-expression of MMP-3 in the fissured tissue may continuously aggravate the cleft condition in the later life.
Adult
;
Antibodies
;
Cadherins
;
Cathepsin G
;
Cleft Lip*
;
Follicular Cyst
;
Humans
;
Hyperplasia
;
Lip
;
Melanocytes
;
Mouth Mucosa
;
Outcome Assessment (Health Care)
;
Palate*
;
Proliferating Cell Nuclear Antigen
;
Sebaceous Glands
;
Skin
;
Vascular Endothelial Growth Factor A
2.Acute myocardial infarction in the young adults.
Myeong Ki HONG ; Seung Yun CHO ; Bum Kee HONG ; Kil Jin CHANG ; Ick Mo CHUNG ; Moon Hyung LEE ; Sang Wook LIM ; Huck Moon KWON ; Yang Soo JANG ; Nam Sik CHUNG ; Won Heum SHIM ; Sung Soon KIM
Yonsei Medical Journal 1994;35(2):184-189
A review was done on 631 patients with acute myocardial infarction who underwent coronary angiography within 30 days after onset of myocardial infarction at Yonsei University Severance Hospital from January, 1985, to August, 1993. The incidence of acute myocardial infarction in patients under 40 years of age was 10.3% (65/631). Acute myocardial infarction below the fourth decades was the predominant disease of men. Risk factor analysis revealed a history of cigarette smoking and hypercholesterolemia were more frequently found in the young patients, but a history of hypertension and diabetes were more frequently found in the elderly patients. Angiographically, the incidence of one vessel disease and normal or minimal lesion coronary anatomy were more frequent in the young patients and incidence of multi-vessel disease were more frequent in the elderly patients. Of the 65 patients under 40 with acute myocardial infarction, the patients with multi-vessel disease tended to have a history of diabetes mellitus in comparison with those with normal coronary anatomy or one vessel disease.
Adult
;
Age Factors
;
Female
;
Human
;
Incidence
;
Korea/epidemiology
;
Male
;
Middle Age
;
Myocardial Infarction/*epidemiology
;
Prevalence
;
Risk Factors
3.The Effectiveness of 100mg of Double Bolus Recombinant Tissue Plasminogen Activator in the Treatment of Acute Myocardial Infarction : Multicenter Trial.
Sang Sig CHEONG ; Seung Jung PARK ; Seong Wook PARK ; Myeong Ki HONG ; Duk Hyun KANG ; Jae Joong KIM ; Jae Kwan SONG ; Kyoung Ah KIM ; Jong Koo LEE ; Seung Jea TAHK ; Han Soo KIM ; Huck Moon KWON ; Young Cheoul DOO ; Chong Yun RIM
Korean Circulation Journal 1995;25(4):717-722
BACKGROUND: The early coronary reperfusion with tissue type plasminogen activator(t-PA) influenced on the short term mortality and long term mobidity in acute myocardial infarction. The attention for thrombolysis with t-PA has been focused in identifying the optimal t-PA regimen and on the possibility of achieving effective and safe thrombolysis with a bolus of t-PA. Experimental data demonstrates that rapid t-PA infusion resulted in improved thrombolysis with minimal fibrinogenolysis and without excessive bleeding than prolonged infusion. METHODS: Consecutive patients presenting up to 6 hour from the onset of symptoms were recruited for the study. Aspirin(200mg daily) should be given immediately, 100mg t-PA was administered as two intravenous bolus injections of 50mg t-PA each given 30 minute apart, and followed by 5,000 unit heparin IV bolus with continuous infusion for 5 days. Angiography was performed at 60 and 90min after the first bolus and between 12-24 hour after study entry. After 7-10 days of myocardial infacrtion, coronary angiograms were performed in all patients who had been taken ddouble bolus t-PA. RESULTS: At 60min, angiography revealed infarct-related coronary artery patency of TIMI flow grade 3 in 15(88%) of 17 patients. At 90min, infarct-related coronary artery patency of TIMI flow grade 3 was achieved in 16(94%) of 17 patients. Bleeding episodes were mostly minor(6 of 33 patients, 18%), and hemorrhagic stroke was developed in 1 patients(1/33, 3.0%). Three patients(9.0%) died in hospitalization probably due to ventricular rupture. CONCLUSION: The administration of 100mg of double bolus t-PA in acute myocardial infarcion results in remarkably high early TIMI flow grade 3 on infarct-related coronary artery patency rates(88% and 94% at 60 and 90min, respectively). The bolus injection of t-PA may be simple and effective strategy in the treatment of acute myocardial infarction. However, large numbers of prospective study would be required.
Angiography
;
Coronary Vessels
;
Hemorrhage
;
Heparin
;
Hospitalization
;
Humans
;
Mortality
;
Myocardial Infarction*
;
Myocardial Reperfusion
;
Plasminogen
;
Rupture
;
Stroke
;
Tissue Plasminogen Activator*